Status:
UNKNOWN
Association Between ABO Polymorphism and Gastric/Colorectal Cancers
Lead Sponsor:
Assiut University
Conditions:
Gastric Cancer
Colo-rectal Cancer
Eligibility:
All Genders
Brief Summary
To assess ABO gene polymorphism (rs8176746) in the patients histopathologically confirmed gastric and/or colorectal cancers relative to healthy controls by real time PCR.
Detailed Description
The ABO blood group system was discovered by the Austrian pathologist Karl Landsteiner in 1901, who classified the blood groups based on the presence of A and B antigens on the surface of red blood ce...
Eligibility Criteria
Inclusion
- Patients that histopathologically confirmed gastric and/or colorectal cancer.
- males and females.
Exclusion
- Presence of other haematological , autoimmune disorders or other malignancies.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT06149923
Start Date
December 1 2023
End Date
January 1 2026
Last Update
November 29 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.